AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas – Respiratory and Autoimmunity, Cardiovascular and Metabolic Diseases, and Oncology.
See below for the Latest AstraZeneca News, Analysis, Profit Results, Share Price Information, and Commentary.
AstraZeneca unveils new R&D centre in Hong Kong
AstraZeneca unveils new R&D centre in Hong Kong
The R&D centre will focus on cell and gene therapy studies.
AstraZeneca HK, Lippo Healthcare partner for health innovation in GBA
The collaboration will address healthcare challenges in treating chronic diseases.
Commentary
In the age of AI, creativity is the decisive advantage
Hong Kong cleared stablecoins for take-off. Getting them to work across Asia is the hard part
Why Hong Kong’s retail product reshuffle may favour large suppliers